TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $51,090,221 | +12.1% | 4,318,700 | -43.9% | 1.21% | +17.8% |
| Q3 2022 | $45,595,000 | +59.0% | 7,701,870 | +14.1% | 1.03% | +45.1% |
| Q2 2022 | $28,677,000 | -54.8% | 6,747,549 | +1.0% | 0.71% | -36.6% |
| Q1 2022 | $63,505,000 | -44.6% | 6,677,726 | +10.7% | 1.12% | -13.9% |
| Q4 2021 | $114,663,000 | +4.5% | 6,034,875 | +83.1% | 1.30% | +17.2% |
| Q3 2021 | $109,706,000 | +0.3% | 3,296,451 | +16.9% | 1.11% | +7.6% |
| Q2 2021 | $109,430,000 | -23.6% | 2,821,079 | -5.1% | 1.03% | -22.1% |
| Q1 2021 | $143,209,000 | -14.0% | 2,971,136 | -7.2% | 1.32% | -50.5% |
| Q4 2020 | $166,571,000 | +41.7% | 3,202,061 | -27.1% | 2.67% | +22.1% |
| Q3 2020 | $117,535,000 | +4540.2% | 4,392,196 | +3277.6% | 2.18% | +4022.6% |
| Q2 2020 | $2,533,000 | – | 130,039 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |